C. Gaffory

发表

Corrélation des altérations génétiques à l’agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1

O. Cussenot, O. Traxer, S. Doizi, 2017 .

Effect of Genetic Variability within 8q24 on Aggressiveness Patterns at Diagnosis and Familial Status of Prostate Cancer

G. Cancel-Tassin, O. Cussenot, A. Valéri, 2008, Clinical Cancer Research.

Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)

G. Cancel-Tassin, O. Cussenot, M. Romana, 2014, Asian journal of andrology.

Region 2 of 8 q 24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe ( French West Indies )

O. Cussenot, M. Romana, P. Blanchet, 2022 .

Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.

G. Cancel-Tassin, O. Cussenot, M. Rouprêt, 2014, The Journal of urology.

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up

G. Cancel-Tassin, O. Cussenot, M. Rouprêt, 2021, World Journal of Urology.

Phenol Sulfotransferase SULT1A1*2 Allele and Enhanced Risk of Upper Urinary Tract Urothelial Cell Carcinoma

F. Hamdy, G. Cancel-Tassin, O. Cussenot, 2007, Cancer Epidemiology Biomarkers & Prevention.

Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer

G. Cancel-Tassin, O. Cussenot, F. Haab, 2013, The Prostate.

Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.

D. Cox, G. Cancel-Tassin, O. Cussenot, 2016, European urology.